Verena Crosato

Dr. Verena Crosato


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2024 in AIDS and Behavior
Verified
Journal Article
Open access
PDF file
VCVerena Crosato
Verena Crosato
BFBeatrice Formenti
Beatrice Formenti
MGMaurizio Gulletta
Maurizio Gulletta
SOSilvia Odolini
Silvia Odolini
SCSilvia Compostella
Silvia Compostella
FCFrancesco Castelli
Francesco Castelli
Before 2022, monkeypox virus (Mpox) infection in humans was seldom reported outside Africa. During the May 2022 outbreak, most cases were detected among men who have sex with men (MSM). Since Mpox is largely unknown to the general population, through a self-completion questionnaire, we investigated the behaviours and knowledge of our at-risk population belonging to the sexually transmitted infection (STI) outpatient clinic of the Infectious Diseases Unit of the ASST Spedali Civili of Brescia, Italy, between August and October 2022. Most patients that took part in the compilation are HIV positive MSM. The other participants were HIV-seronegative patients with other STIs. Overall, 144 questionnaires were compiled. Most of the participants were Italians (130;90%) and males (139;96.5%) between 30 and 60 years (118;82%). Almost all (136;94%) reported having heard about Mpox and more than half (80;56%) received information about the transmission. Twenty-four respondents (16%) received information from health professionals and 14 (10%) believed that the information received was complete. Although 41% of respondents thought they were at risk of getting the infection and 62% were afraid to get it, the majority (56%) did not increase the precautions taken. When asked if they would accept a vaccine to prevent the disease, more than a third (32%) of respondents expressed hesitation or complete refusal to be vaccinated. Based on our results, what emerges is that there is still a lack of knowledge and awareness about Mpox. To address this issue, targeted health promotion and education strategies that provide the necessary resources to reduce risk behaviours and enhance connections with healthcare professionals are needed.

13 January 2023 in Infection
Verified
Journal Article
Open access
PDF file
VCVerena Crosato
Verena Crosato
MAMelania Degli Antoni
Melania Degli Antoni
IIIlaria Izzo
Ilaria Izzo
CCCarlo Cerini
Carlo Cerini
FPFrancesca Pennati
Francesca Pennati
FCFrancesco Castelli
Francesco Castelli
The outbreak of monkeypox virus (MPXV) in non-endemic countries is an international public health emergency, and the diversity in manifestations poses challenges for early diagnosis and isolation. We describe an atypical case of monkeypox (MPX) in a 46-year-old homosexual male living with HIV. He reported 1-day duration fever, a lesion on his chin that, over a period of 18 days, had gradually enlarged and ulcerated. Biopsy examination performed at an external centre revealed pyoderma gangrenosum, unconfirmed at a subsequent biopsy. When he reported to our hospital outpatients’ clinic the chin lesion had a diameter of 5 × 5 cm, necrotic margins and ulcerated base and signs of superinfection. He was admitted for further investigations. Three swabs collected from pharynx, skin and chin lesion resulted positive for MPXV. He had a favourable clinical course and was discharged soon after. Pending the achievement of optimal vaccination coverage in at-risk groups, early identification and isolation of infectious patients represent the cornerstones of the containment strategy. Atypical cases of MPX manifestations are not uncommon, particularly in patients with HIV infection. A high level of suspicion should be maintained to identify infectious cases at an early stage and avoid further spread of the infection.

16 February 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
AMAlice Mulè
Alice Mulè
VCVerena Crosato
Verena Crosato
DKDouglas B. Kuhns
Douglas B. Kuhns
LLLuisa LORENZI
Luisa LORENZI
CCClaudia Chirico
Claudia Chirico
LTLina Tomasoni
Lina Tomasoni
Visceral leishmaniasis (VL) is a parasitic zoonosis caused by Leishmania spp. that usually manifests itself in immunocompromised subjects. It is a rare and neglected disease, and it is not endemic in the province of Brescia (Italy). Three cases of human VL occurred in Brescia from October to December 2021 in immunocompetent patients. We evaluated the patients looking for signs of underlying immunodeficiencies and conducted further epidemiological evaluations in the province of Brescia without success. An analysis of the sera levels of the main cytokines involved in the immune response to VL was performed. All patients presented a significant augmentation of CXCL-10, CCL-4, and IL-6. The patients tested during the acute phase showed an elevation of IL-1α, IL-5, IL-10, and IL-12, while in the recovery phase, higher levels of TNF-α and IL-7 were detected. Altogether, a predominant activation of the T-helper-2 pathway emerged during the acute phase of the parasite infection, while the cytokines associated with the T-helper-1 pathway were less represented. This imbalanced immune response to the parasite infection might play a crucial role in the development of VL in immunocompetent patients.

23 April 2023 in Tomography
Verified
Journal Article
Open access
PDF file
MAMelania Degli Antoni
Melania Degli Antoni
VCVerena Crosato
Verena Crosato
FPFrancesca Pennati
Francesca Pennati
ABAndrea Borghesi
Andrea Borghesi
GCGraziella Cristini
Graziella Cristini
EFEmanuele Focà
Emanuele Focà
X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by marked reduction in serum immunoglobulins and early-onset infections. Coronavirus Disease-2019 (COVID-19) pneumonia in immunocompromised patients presents clinical and radiological peculiarities which have not yet been completely understood. Very few cases of agammaglobulinemic patients with COVID-19 have been reported since the beginning of the pandemic in February 2020. We report two cases of migrant COVID-19 pneumonia in XLA patients.

29 November 2022 in Research Square
Verified
Preprint
Open access
PDF file
VCVerena Crosato
Verena Crosato
MAMelania Degli Antoni
Melania Degli Antoni
IIIlaria Izzo
Ilaria Izzo
CCCarlo Cerini
Carlo Cerini
FPFrancesca Pennati
Francesca Pennati
FCFrancesco Castelli
Francesco Castelli
The outbreak of monkeypox virus (MPXV) in non-endemic countries is an international public health emergency and the diversity in manifestations poses challenges for early diagnosis and isolation. We describe an atypical case of monkeypox (MPX) in a 46-year-old homosexual male with compensated HIV infection. He reported one day duration fever, a lesion on his chin that, over a period of 18 days, had gradually enlarged and ulcerated. Biopsy examination performed at an external centre revealed pyoderma gangrenous, unconfirmed at a subsequent biopsy. When he reported to our hospital outpatients’ clinic the chin lesion had a diameter of 5x5 cm, necrotic margins and ulcerated base and signs of superinfection. was admitted for further investigations. Three swabs collected from pharynx, skin, and chin lesion resulted positive for MPXV. He had a favourable clinical course and was discharged soon after. Pending the achievement of optimal vaccination coverage in at-risk groups, early identification and isolation of infectious patients represent the cornerstones of the containment strategy. Atypical cases of MPX manifestations are not uncommon, particularly in patients with HIV infection. A high level of suspicion should be maintained to identify infectious cases at an early stage and avoid further spread of the infection.